ReviewGut microbes
Biomarkers of Helicobacter pylori-associated gastric cancer.
Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 25 citations in OpenAlex.
- Comparative insights intoFrontiers in microbiology · 2025Review
- An ingestible device for automated sampling and location tracing in gastrointestinal tract.PloS one · 2025Article
- Genetic and epigenetic instability induced by betel quid associated chemicals.Toxicology reports · 2023Review
- High expression of GNB4 predicts poor prognosis in patients withTranslational cancer research · 2020Article
- BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation.Theranostics · 2019Article
- Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric CancerIranian biomedical journal · 2018Article
- Evaluation of altered expression ofJournal of gastrointestinal oncology · 2018Article
- Julian Davies and the discovery of kanamycin resistance transposon Tn5.The Journal of antibiotics · 2017Review
- Host pathogen interactions inWorld journal of gastroenterology · 2017Review
- Correlation of Helicobacter pylori and interleukin-8 mRNA expression in high risk gastric cancer population prediction.World journal of gastrointestinal oncology · 2016Article
- Dietary amelioration of Helicobacter infection.Nutrition research (New York, N.Y.) · 2015Review
- Implementation of gastric cancer screening - the global experience.Best practice & research. Clinical gastroenterology · 2014Review
- Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?World journal of microbiology & biotechnology · 2014Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
Abstract
Helicobacter pylori-associated gastric cancer is a major cause of morbidity and mortality worldwide, and is predicted to become even more common in developing countries as the population ages. Since gastric cancer develops slowly over years to decades, and typically progresses though a series of well-defined histologic stages, cancer biomarkers have potential to identify asymptomatic individuals in whom surgery might be curative, or even those for whom antibiotics to eradicate H. pylori could prevent neoplastic transformation. Here we describe some of the challenges of biomarker discovery, summarize current approaches to biomarkers of gastric cancer, and explore some recent novel strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.